---
layout: template1
title: Research
---

### Group Interests

Non-coding RNAs; microRNAs; piwiRNAs; lncRNAs; circularRNAs; extracellular vesicles; exosomes; biomarkers; lung cancer; colorectal cancer; lymphoma; leukemia; Hodgkin lymphoma; Multiple myeloma; organoids;

### Publications

Below we have included selected papers describing some of our best known work.



#### Last publications

-[Impact of piR_004530 reactivation in lung cancer: implications for recurrence and survival of lung squamous cell carcinoma patients.](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-04342-1)
Yangyi He, Melissa Acosta-Plasencia, David Sánchez-Lorente, Nuria Viñolas, Daniel Martinez, Tania Díaz, Antonio Altuna-Coy, Risha Na, Yi Liu, Marc Boada, Angela Guirao, Laureano Molins, Ramón M. Marrades and Alfons Navarro. 
BMC Medicine 2025 23:537

<audio controls style="margin-top:10px;">
  <source src="Resumen_piR_004530.m4a" type="audio/mp4">
  Tu navegador no soporta el elemento de audio.
</audio>

-[Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients](https://www.mdpi.com/1422-0067/26/7/2870)
Yangyi He, Antonio Altuna-Coy, Melissa Acosta-Plasencia, Laureano Molins, David Sánchez-Lorente, Daniel Martinez, Tania Díaz, Risha Na, Ramón M. Marrades and Alfons Navarro. 
Int. J. Mol. Sci. 2025, 26(7), 2870. 

-[Selection of the Most Suitable Culture Medium for Patient-Derived Lung Cancer Organoids.](https://karger.com/cto/article/doi/10.1159/000541274/912835/Selection-of-the-Most-Suitable-Culture-Medium-for)
M Acosta-Plasencia, Y He,  D Martínez,  JP Orozco,  A Carrasco, A Altuna-Coy, T Yang, T Díaz, L Molins, R Ramos, RM Marrades,  A Navarro.
Cells Tissues Organs. 2024 September 5:1-21. 

-[Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation.](https://stemcellres.biomedcentral.com/articles/10.1186/s13287-024-03883-1)
M Acosta-Plasencia, JJ Castellano, T Diaz, Y He, RM Marrades, A Navarro.
Stem Cell Research & Therapy. 2024 August 26;15(1):263. 

-[Analysis of tumor-draining vein secretome: A direct access to tumor-derived extracellular vesicles in surgical lung cancer patients.](https://doi.org/10.32604/biocell.2023.027718)
Y He, D Sanchez-Lorente, M Acosta-Plasencia, ..., A Navarro.
Biocell. 2023 April 10;47(5):951-957. 

-[Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer.](https://www.mdpi.com/1422-0067/23/13/7138)
B Han, L Molins, Y He, ..., A Navarro.
Int J Mol Sci. 2022 Jun 27;23(13):7138.

-[Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.](https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02206-z) 
J Canals, A Navarro, C Vila, ...
J Exp Clin Cancer Res. 2022 Jan 26;41(1):37.  

#### Reviews

-[Epigenetic regulation mechanisms of microRNA expression.](https://pubmed.ncbi.nlm.nih.gov/29161231/)
S Morales, M Monzo, A Navarro.
Biomolecular concepts 8 (5-6), 203-212.

-[Non-coding RNAs in Hodgkin lymphoma.](https://pubmed.ncbi.nlm.nih.gov/28555062/)
A Cordeiro, M Monzó, A Navarro.
International journal of molecular sciences 18 (6), 1154.

-[MIR135A1 (microRNA 135a-1).](http://atlasgeneticsoncology.org/Genes/GC_MIR135A1.html)
A Navarro, M Díaz-Beyá, M Monzó.
Atlas of Genetics and Cytogenetics in Oncology and Haematology.

-[MicroRNAs in human embryonic and cancer stem cells.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908867/)
A Navarro, M Monzó.
Yonsei medical journal 51 (5), 622-632.

-[Pharmacogenomics: a tool for improving cancer chemotherapy.](https://pubmed.ncbi.nlm.nih.gov/18940743/)
M Monzo, A Navarro, G Ferrer, R Artells.
Clinical and Translational Oncology 10 (10), 628-637.

#### Editorials

-[Editorial: Evolving roles of piRNAs in solid tumors.](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1178634/full)
Ng L, Navarro A and Law W-L 
Front. Oncol. 2023, 13:1178634. doi: 10.3389/fonc.2023.1178634

-[Deciphering miRNA–Target Relationships to Understand miRNA-Mediated Carcinogenesis.](https://www.mdpi.com/2072-6694/13/10/2415)
A Navarro.
Cancers 2021, 13(10), 2415.

-[Editorial: The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory to Clinical Utility..](https://www.frontiersin.org/articles/10.3389/fonc.2020.631316/full)
Zhou J-G, Huang Z, Slaby O and Navarro A 
Front. Oncol. 2021, 10:631316. 

-[Clinic and therapeutic potential of non-coding RNAs in cancer.](https://tcr.amegroups.com/article/view/48756)
JJ Castellano, M Diaz-Beya, A Navarro.
Transl Cancer Res 10 (6). 


-[Can long non-coding RNAs reveal the hidden code of lung cancer?.](https://ncri.amegroups.com/article/view/5871/html)
JJ Castellano, A Navarro.
Non-coding RNA Investigation, 2020, vol. 4, num. 6.

-[Twist1 activated circRNA-10720 is a new player in hepatocellular carcinoma metastasis.](https://tcr.amegroups.com/article/view/26206/html)
A Navarro.
Transl Cancer Res 8 (S2), S135-S140.

-[Argonaute-crosslinking and immunoprecipitation deciphers the liver miR-122 targetome.](https://ncri.amegroups.com/article/view/3924/4567)
A Navarro.
Non-coding RNA Investig 1, 23.

-[Genotypes and chemotherapy toxicity.](https://doi.org/10.2217/14622416.10.3.335)
M Monzo, A Navarro.
Pharmacogenomics vol. 10, num. 3. 

-[Genetic Predictors of Leukocytopenia severity.](https://doi.org/10.2217/14622416.10.3.335)
M Monzo, A Navarro.
Pharmacogenomics vol. 10, num. 3. 

#### Interviews

-[Interview with Dr. Alfons Navarro: non-coding RNAs as cancer biomarkers.](https://tcr.amegroups.org/post/view/interview-with-dr-alfons-navarro-non-coding-rnas-as-cancer-biomarkers)
Alfons Navarro, Lily Yu, Margo Y. Chen.
Translational Cancer Research. Posted On 2024-07-08.

#### MicroRNAs

-[miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.](https://academic.oup.com/carcin/article/30/11/1903/2629506?login=true)
E Gallardo, A Navarro, N Vinolas, RM Marrades, T Diaz, B Gel, A Quera, ...
Carcinogenesis 30 (11), 1903-1909.

-[Overlapping expression of microRNAs in human embryonic colon and colorectal cancer.](https://www.nature.com/articles/cr200881)
M Monzo, A Navarro, E Bandres, R Artells, I Moreno, B Gel, R Ibeas, ...
Cell research 18 (8), 823-833.

-[MicroRNA expression profiling in classic Hodgkin lymphoma.](https://ashpublications.org/blood/article/111/5/2825/109935/MicroRNA-expression-profiling-in-classic-Hodgkin)
A Navarro, A Gaya, A Martinez, A Urbano-Ispizua, A Pons, O Balagué, ...
Blood, The Journal of the American Society of Hematology 111 (5), 2825-2832.

-[Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.](https://ashpublications.org/blood/article/114/14/2945/107846/Regulation-of-JAK2-by-miR-135a-prognostic-impact)
A Navarro, T Diaz, A Martinez, A Gaya, A Pons, B Gel, C Codony, G Ferrer, ...
Blood, The Journal of the American Society of Hematology 114 (14), 2945-2951.

-[Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.](https://www.nature.com/articles/leu2012278)
M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, ...
Leukemia 27 (3), 595-603.

-[MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.](https://www.nature.com/articles/leu2013281)
M Diaz-Beya, S Brunet, J Nomdedeu, R Tejero, T Diaz, M Pratcorona, ...
Leukemia 28 (4), 804-812

#### LncRNAs

-[LincRNA-p21 impacts prognosis in resected non–small cell lung Cancer patients through angiogenesis regulation.](https://www.jto.org/article/S1556-0864(16)30692-X/fulltext)
JJ Castellano, A Navarro, N Viñolas, RM Marrades, J Moises, A Cordeiro, ...
Journal of Thoracic Oncology 11 (12), 2173-2182.

#### PiwiRNAs

-[PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.](https://www.oncotarget.com/article/10015/text/)
A Cordeiro, A Navarro, A Gaya, M Díaz-Beyá, B Gonzalez-Farré, ...
Oncotarget 7 (29), 46002-46013.

-[The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.](https://www.oncotarget.com/article/3003/text/)
A Navarro, R Tejero, N Viñolas, A Cordeiro, RM Marrades, D Fuster, ...
Oncotarget 6 (31), 31544.

#### CircRNAs

-[Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.](https://pubmed.ncbi.nlm.nih.gov/34012794/)
J Martín, JJ Castellano, RM Marrades, J Canals, N Viñolas, T Díaz, ...
Translational Lung Cancer Research 10 (4), 1804



#### Extracellular vesicles (exosomes) and non-coding RNAs

-[Extracellular vesicle lincRNA-p21 expression in tumor-draining pulmonary vein defines prognosis in NSCLC and modulates endothelial cell behavior.](https://www.mdpi.com/2072-6694/12/3/734)
JJ Castellano, RM Marrades, L Molins, N Viñolas, J Moises, J Canals, ...
Cancers 12 (3), 734

-[Exosome analysis in tumor-draining pulmonary vein identifies NSCLC patients with higher risk of relapse after curative surgery.](https://www.mdpi.com/2072-6694/11/2/249)
A Navarro, L Molins, RM Marrades, J Moises, N Viñolas, S Morales, ...
Cancers 11 (2), 249


#### Pharmacogenomics

-[Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.](https://aacrjournals.org/clincancerres/article/18/13/3697/287310/Impact-of-MiRSNPs-on-Survival-and-Progression-in)
CF de Larrea, A Navarro, R Tejero, N Tovar, T Díaz, MT Cibeira, L Rosinol, ...
Clinical cancer research 18 (13), 3697-3704.

-[Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.](https://ashpublications.org/blood/article/107/12/4871/129260/Genomic-polymorphisms-provide-prognostic)
M Monzo, S Brunet, A Urbano-Ispizua, A Navarro, G Perea, J Esteve, ...
Blood 107 (12), 4871-4879.

-[MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients.](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064716)
A Navarro, C Munoz, A Gaya, M Díaz-Beyá, B Gel, R Tejero, T Díaz, ...
PloS one 8 (5), e64716

-[A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0022509)
M Campayo, A Navarro, N Vinolas, R Tejero, C Munoz, T Diaz, ...
PloS one 6 (7), e22509

-[Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with stage I to II head-and-neck cancer.](https://www.redjournal.org/article/S0360-3016(06)01121-7/fulltext)
J Carles, M Monzo, M Amat, S Jansa, R Artells, A Navarro, P Foro, ...
International Journal of Radiation Oncology* Biology* Physics 66 (4), 1022-1030.

-[Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.](https://ashpublications.org/blood/article/112/10/4337/24611/Common-variants-in-NLRP2-and-NLRP3-genes-are)
M Granell, A Urbano-Ispizua, A Pons, JI Aróstegui, B Gel, A Navarro, ...
Blood, The Journal of the American Society of Hematology 112 (10), 4337-4342











